OR8D4 inhibitors are a class of chemical compounds specifically designed to block the activity of the OR8D4 olfactory receptor, a member of the G protein-coupled receptor (GPCR) family. OR8D4 is involved in the detection of specific odorant molecules and the initiation of olfactory signal transduction, which leads to the perception of distinct smells. These inhibitors work by binding directly to the receptor, either at its active or allosteric sites, preventing the receptor from interacting with its natural ligands. By doing so, they effectively block the signal transmission that would typically result from odorant binding, allowing for precise control and modulation of the receptor's activity.
OR8D4 inhibitors consist primarily of small organic molecules engineered to fit precisely within the receptor's binding domains. Structural analyses of the OR8D4 receptor provide insights into the shape and chemical properties of these binding sites, allowing researchers to design inhibitors that interact specifically with OR8D4. These inhibitors are identified and optimized through methods such as molecular docking and structure-activity relationship (SAR) studies, which refine the interactions between the compound and the receptor. Once bound, OR8D4 inhibitors prevent the conformational changes in the receptor that are necessary for signal transduction. These inhibitors are crucial tools for studying olfactory receptor function, offering researchers the ability to dissect the specific roles OR8D4 plays in the broader olfactory signaling network and enhancing the understanding of how individual receptors contribute to odor perception in complex environments.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide halts eukaryotic protein synthesis by inhibiting peptide elongation, which would directly reduce the production of OR8D4 proteins in olfactory cells. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Geldanamycin binds selectively to heat shock protein 90 (Hsp90), potentially leading to the destabilization and subsequent degradation of improperly folded OR8D4 proteins. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A interrupts protein trafficking by blocking the function of the Golgi apparatus, leading to a decrease in the surface expression of OR8D4 receptors. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132 blocks proteasomal degradation pathways, causing an accumulation of defective proteins which may include misfolded OR8D4, leading to its enhanced breakdown. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $42.00 $214.00 $832.00 $66.00 | 394 | |
Puromycin induces premature termination of mRNA translation, effectively decreasing the synthesis rate of the OR8D4 protein. | ||||||
Concanamycin A | 80890-47-7 | sc-202111 sc-202111A sc-202111B sc-202111C | 50 µg 200 µg 1 mg 5 mg | $66.00 $167.00 $673.00 $2601.00 | 109 | |
Concanamycin A disrupts cellular pH gradients by inhibiting vacuolar-type H+-ATPases, which could lead to improper processing and reduced stability of OR8D4. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine compromises lysosomal degradation processes, which could hinder the breakdown pathway of the OR8D4 receptor, leading to its decreased functional expression. | ||||||
GW4869 | 6823-69-4 | sc-218578 sc-218578A | 5 mg 25 mg | $203.00 $611.00 | 24 | |
GW4869 blocks the synthesis of exosomes, possibly leading to a reduction in the extracellular signaling required for normal OR8D4 expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin suppresses mTOR pathway signaling, crucial for protein synthesis, thereby reducing the cellular production of OR8D4 receptors. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin prevents N-linked glycosylation of proteins, a process vital for the proper folding and function of GPCRs like OR8D4, leading to its decreased expression. | ||||||